These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38381808)
21. Nanomedicines for an Enhanced Immunogenic Cell Death-Based Zhao C; Wang C; Shan W; Wang Z; Chen X; Deng H Acc Chem Res; 2024 Mar; 57(6):905-918. PubMed ID: 38417027 [TBL] [Abstract][Full Text] [Related]
22. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy. Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775 [TBL] [Abstract][Full Text] [Related]
23. Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage. Yu TT; Hu J; Li QR; Peng XC; Xu HZ; Han N; Li LG; Yang XX; Xu X; Yang ZY; Chen H; Chen X; Wang MF; Li TF Int Immunopharmacol; 2023 Feb; 115():109661. PubMed ID: 36608440 [TBL] [Abstract][Full Text] [Related]
24. Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma. Miao Z; Li J; Zeng S; Lv Y; Jia S; Ding D; Li W; Liu Q ACS Appl Mater Interfaces; 2024 Jan; 16(1):245-260. PubMed ID: 38113527 [TBL] [Abstract][Full Text] [Related]
25. Light-Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy. An X; Chen Z; Luo Y; Yang P; Yang Z; Ji T; Chi Y; Wang S; Zhang R; Wang Z; Li J Adv Sci (Weinh); 2024 Sep; 11(33):e2403158. PubMed ID: 38953329 [TBL] [Abstract][Full Text] [Related]
26. A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune. Jiang Z; Cai G; Liu H; Liu L; Huang R; Nie X; Gui R; Li J; Ma J; Cao K; Luo Y J Nanobiotechnology; 2024 May; 22(1):296. PubMed ID: 38811964 [TBL] [Abstract][Full Text] [Related]
27. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer. He H; Liu L; Liang R; Zhou H; Pan H; Zhang S; Cai L Acta Biomater; 2020 Mar; 104():188-197. PubMed ID: 31945508 [TBL] [Abstract][Full Text] [Related]
28. Designing Theranostic Agents Based on Pluronic Stabilized Gold Nanoaggregates Loaded with Methylene Blue for Multimodal Cell Imaging and Enhanced Photodynamic Therapy. Simon T; Potara M; Gabudean AM; Licarete E; Banciu M; Astilean S ACS Appl Mater Interfaces; 2015 Aug; 7(30):16191-201. PubMed ID: 26151097 [TBL] [Abstract][Full Text] [Related]
29. BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma. Liu Z; Zhang J; Liu H; Shen H; Meng N; Qi X; Ding K; Song J; Fu R; Ding D; Feng G Adv Mater; 2023 Feb; 35(7):e2208692. PubMed ID: 36529696 [TBL] [Abstract][Full Text] [Related]
30. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy. Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821 [TBL] [Abstract][Full Text] [Related]
31. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751 [TBL] [Abstract][Full Text] [Related]
32. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death. Jin F; Liu D; Xu X; Ji J; Du Y Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518 [TBL] [Abstract][Full Text] [Related]
33. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy. Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711 [TBL] [Abstract][Full Text] [Related]
34. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. Li Z; Lai X; Fu S; Ren L; Cai H; Zhang H; Gu Z; Ma X; Luo K Adv Sci (Weinh); 2022 Aug; 9(22):e2201734. PubMed ID: 35652198 [TBL] [Abstract][Full Text] [Related]
35. Corn-like Au/Ag nanorod-mediated NIR-II photothermal/photodynamic therapy potentiates immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Jin L; Shen S; Huang Y; Li D; Yang X Biomaterials; 2021 Jan; 268():120582. PubMed ID: 33302120 [TBL] [Abstract][Full Text] [Related]
36. Mitochondrial Localized In Situ Self-Assembly Reprogramming Tumor Immune and Metabolic Microenvironment for Enhanced Cancer Therapy. Wang Z; Wang Q; Cao H; Wang Z; Wang D; Liu J; Gao T; Ren C; Liu J Adv Mater; 2024 Apr; 36(15):e2311043. PubMed ID: 38190762 [TBL] [Abstract][Full Text] [Related]
37. Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death. Tu K; Deng H; Kong L; Wang Y; Yang T; Hu Q; Hu M; Yang C; Zhang Z ACS Appl Mater Interfaces; 2020 Apr; 12(14):16018-16030. PubMed ID: 32192326 [TBL] [Abstract][Full Text] [Related]
38. Self-Delivery Photodynamic Re-educator Enhanced Tumor Treatment by Inducing Immunogenic Cell Death and Improving Immunosuppressive Microenvironments. Kong RJ; Li YM; Huang JQ; Yan N; Wu YY; Cheng H ACS Appl Mater Interfaces; 2023 Dec; 15(51):59165-59174. PubMed ID: 38100370 [TBL] [Abstract][Full Text] [Related]
39. Bio-responsive Au-miR-183 inhibitor enhances immunotherapy in hepatocellular carcinoma by inducing immunogenic cell death. Yin L; Wei Y; Liu Y; Mo X; Song J; Cai W J Control Release; 2024 Apr; 368():498-517. PubMed ID: 38428529 [TBL] [Abstract][Full Text] [Related]
40. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors. Xiao G; Zhao Y; Wang X; Zeng C; Luo F; Jing J Front Immunol; 2023; 14():1279221. PubMed ID: 37942337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]